---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-010591"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2026-03-20T23:59:59+00:00"
generated_at: "2026-05-15T09:28:05.229786+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Femasys amends convertible notes, removes anti-dilution, issues 16.4M warrants at $0.58; board adds director

## Summary
- Omnibus Amendment removes Share Combination Event Adjustment from $10.5M+ senior secured convertible notes and warrants, effective Dec 31, 2025.
- As consideration, lenders receive 16,378,563 Series D-1 Warrants exercisable at $0.58 per share (Nasdaq minimum price on March 19, 2026).
- Director Joshua Silverman resigned March 17, 2026; no disagreement. Board appointed Kenneth D. Eichenbaum, M.D., effective March 18, 2026.
- Amendment expands Securities Purchase Agreement participation right exclusion to cover Series D-1 Warrants and underlying shares.

## SEC filing metadata
- accession: 0001140361-26-010591
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2026-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/0001140361-26-010591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/ef20068469_form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-010591
- JSON: https://secwatch.observer/filing/0001140361-26-010591.json
- Plain text: https://secwatch.observer/filing/0001140361-26-010591.txt

## Key facts
- Material Agreements
  FEMASYS INC amended Omnibus Amendment and Consent Agreement with Consenting Holders (effective 2026-03-19).
  - Action: amendment
  - Counterparty: Consenting Holders
  - Effective: 2026-03-19
  source text: On March 19, 2026, the Company entered into an Omnibus Amendment and Consent Agreement (the “Amendment Agreement”) with the holders listed on Schedule I thereto (each, a “Consenting Holder” and collectively, the “Consenting Holders”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/0001140361-26-010591-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.